• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Light-based imaging 'sees' thin fibrous cap

Article

Autopsy studies indicate that soft plaque with a fibrous cap measuring less than 65 microns is at risk of imminent rupture. Multislice CT and MR imaging, with resolutions around 200 and 300 microns, respectively, cannot help predict a rupture. Optical coherence tomography (OCT), however, can obtain an in vivo resolution well below 65 microns.

Autopsy studies indicate that soft plaque with a fibrous cap measuring less than 65 microns is at risk of imminent rupture. Multislice CT and MR imaging, with resolutions around 200 and 300 microns, respectively, cannot help predict a rupture. Optical coherence tomography (OCT), however, can obtain an in vivo resolution well below 65 microns.

Dr. Osamu Katoh and colleagues at Toyohashi Heart Center in Japan used OCT to measure minimal and maximal thickness and length of the fibrous caps in stable and vulnerable plaques (Am J Cardiol 2004;94[suppl 6A]:142E). Four lesions were considered vulnerable, and three were considered stable.

The mean minimal thickness of the fibrous caps was significantly less in the vulnerable group (30 microns) than in the stable group (70 microns). The differences in maximal thickness and length between the two groups were not significant.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.